Valentini, Vincenzo
 Distribuzione geografica
Continente #
NA - Nord America 29.194
EU - Europa 22.577
AS - Asia 21.926
SA - Sud America 4.122
AF - Africa 710
OC - Oceania 93
Continente sconosciuto - Info sul continente non disponibili 36
Totale 78.658
Nazione #
US - Stati Uniti d'America 28.218
SG - Singapore 10.109
DE - Germania 7.000
CN - Cina 4.707
SE - Svezia 4.027
BR - Brasile 3.381
IT - Italia 2.762
VN - Vietnam 1.998
FR - Francia 1.934
UA - Ucraina 1.392
IN - India 1.245
IE - Irlanda 1.053
GB - Regno Unito 1.030
ID - Indonesia 724
FI - Finlandia 697
JP - Giappone 564
PL - Polonia 564
NL - Olanda 555
CA - Canada 526
RU - Federazione Russa 506
HK - Hong Kong 471
BD - Bangladesh 382
TR - Turchia 378
AR - Argentina 263
MX - Messico 258
IQ - Iraq 233
BE - Belgio 202
AT - Austria 184
ZA - Sudafrica 179
CZ - Repubblica Ceca 149
PK - Pakistan 142
CI - Costa d'Avorio 135
ES - Italia 132
EC - Ecuador 110
KR - Corea 107
SA - Arabia Saudita 107
IR - Iran 94
MA - Marocco 87
PH - Filippine 85
VE - Venezuela 84
CO - Colombia 74
AU - Australia 73
JO - Giordania 73
UZ - Uzbekistan 73
CL - Cile 65
CH - Svizzera 62
EG - Egitto 61
LT - Lituania 52
KE - Kenya 51
IL - Israele 48
TN - Tunisia 47
AE - Emirati Arabi Uniti 44
PE - Perù 44
JM - Giamaica 41
PY - Paraguay 38
MY - Malesia 37
UY - Uruguay 37
AZ - Azerbaigian 36
KZ - Kazakistan 33
DZ - Algeria 32
RO - Romania 32
NP - Nepal 29
AL - Albania 25
GR - Grecia 25
PT - Portogallo 25
OM - Oman 23
SN - Senegal 23
BO - Bolivia 22
EU - Europa 22
PA - Panama 22
TT - Trinidad e Tobago 21
CR - Costa Rica 20
NO - Norvegia 20
DO - Repubblica Dominicana 19
HN - Honduras 19
RS - Serbia 19
TH - Thailandia 18
DK - Danimarca 17
BG - Bulgaria 16
NZ - Nuova Zelanda 16
ET - Etiopia 15
KG - Kirghizistan 15
LK - Sri Lanka 15
TW - Taiwan 15
AM - Armenia 14
LB - Libano 14
NG - Nigeria 14
NI - Nicaragua 14
BH - Bahrain 13
LV - Lettonia 13
BY - Bielorussia 11
GE - Georgia 11
MD - Moldavia 11
QA - Qatar 11
SY - Repubblica araba siriana 11
A2 - ???statistics.table.value.countryCode.A2??? 10
HR - Croazia 10
LU - Lussemburgo 10
SK - Slovacchia (Repubblica Slovacca) 10
AO - Angola 9
Totale 78.474
Città #
Singapore 5.542
Chandler 4.006
Ashburn 2.771
San Jose 2.747
Beijing 1.047
Dublin 1.046
New York 969
Jacksonville 828
Los Angeles 760
San Mateo 758
Ho Chi Minh City 664
Ann Arbor 634
Jakarta 631
The Dalles 602
Lauterbourg 591
Wilmington 524
Frankfurt am Main 523
Milan 519
Nanjing 510
Hanoi 501
Tokyo 486
Warsaw 482
Rome 449
Munich 436
Amsterdam 426
Hong Kong 417
Boston 405
Woodbridge 378
Hyderabad 361
Hefei 355
Dearborn 348
São Paulo 317
Houston 316
Moscow 292
Princeton 292
Nürnberg 285
Chicago 276
Helsinki 274
Fairfield 271
Marseille 266
Dallas 252
Lawrence 247
Bremen 244
Cattolica 232
Buffalo 227
Izmir 220
Seattle 216
Santa Clara 214
Redwood City 200
Brussels 197
Council Bluffs 180
Nanchang 176
Toronto 169
Zhengzhou 158
St Louis 156
Boardman 155
Abidjan 135
Orem 131
London 129
Brooklyn 117
Paris 116
Nuremberg 113
Montreal 110
Da Nang 109
Shanghai 109
Vienna 106
Atlanta 99
Johannesburg 99
Turku 97
Seoul 92
Shenyang 92
Leawood 91
Tianjin 89
Rio de Janeiro 87
Kunming 86
Phoenix 86
Haiphong 85
Augusta 84
Kent 84
Pune 83
Denver 82
Norwalk 82
Stockholm 81
Washington 81
Düsseldorf 77
Detroit 75
Guangzhou 75
Jiaxing 74
Mexico City 74
Hebei 73
Belo Horizonte 72
Cambridge 72
Chennai 72
Hangzhou 71
Mountain View 69
Brno 68
Amman 67
San Francisco 67
University Park 66
Changsha 65
Totale 40.440
Nome #
Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development 948
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 866
THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy 517
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 376
Combined-modality therapy in locally advanced primary rectal cancer 354
A digital solution to support the activities: Multidisciplinary Tumor Board process and impact analysis 321
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study 313
Neoadjuvant Concurrent Radiochemotherapy in Locally Advanced (IIIa-IIIb) Non-Small Cell Lung Cancer: long term results according to downstaging. 310
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 297
The role of radiotherapy (RT) in the treatment of Adenoid Cystic Carcinoma of the Breast: case report of RT retreatment and literature review 297
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go 293
EP-1325 Personalized Medicine in breast cancer: a nomogram from prognostic score to deescalate radiotherapy 288
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study. 279
Diffusion-Weighted Magnetic Resonance Imaging in Monitoring Rectal Cancer Response to Neoadjuvant Chemoradiotherapy. 269
EP-1181: Prostheses irradiation in breast cancer: clinical and aesthetic outcomes in retrospective series 267
Can Elderly Patients With Newly Diagnosed Glioblastoma be Enrolled in Radiochemotherapy Trials? 266
Multidisciplinary approach in the treatment of T1 glottic cancer. The role of patient preference in a homogenous patient population 254
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 236
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 234
Rectal cancer multidisciplinary treatment: evidences, consensus and perspectives. 231
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 228
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 227
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. 226
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 226
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 225
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 222
Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark? 221
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 219
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 219
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 218
Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators--a pilot study 216
Reducing heart dose during left breast cancer radiotherapy: comparison among 3 radiation techniques 213
Adjuvant radiotherapy in non small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. 211
Personalized Clinical Phenotyping through Systems Medicine and Artificial Intelligence 211
Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome. 210
Medicine is a science of uncertainty and an art of probability (Sir W. Osler) 210
Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092) 208
Vaccines and Myocardial Injury in Patients Hospitalized for COVID-19 Infection: the CardioCOVID-Gemelli Study 205
 ¹⁸F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose. 205
Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis. 204
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 200
A real-time integrated framework to support clinical decision making for covid-19 patients 200
Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. 198
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 198
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 198
A feasibility study of neo-adjuvant low-dose fractionated radiotherapy with two different concurrent anthracycline-docetaxel schedules in stage IIA/B-IIIA breast cancer 197
Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term Analysis 196
The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center 196
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 195
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials 193
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 193
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 192
Experimental evaluation of the impact of low tesla transverse magnetic field on dose distribution in presence of tissue interfaces 192
Outcomes of clinical t4m0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience. 191
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 191
Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma: final report of a pilot study 190
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 189
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 189
Is two-dimensional field definition sufficient for pelvic node coverage in rectal cancer compared to technical three-dimensional definition? 189
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 188
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 188
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 187
A Machine Learning Predictive Model of Bloodstream Infection in Hospitalized Patients 186
Oncological outcome in advanced laryngeal cancers treated with different modalities in a single institution. A retrospective analysis on 65 cases. 186
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 185
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 185
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 183
Multiple abscesses in a patient treated with cetuximab 183
Clinical validation of atlas-based auto-segmentation of pelvic volumes and normal tissue in rectal tumors using auto-segmentation computed system 182
Lung abnormalities at multimodality imaging after radiation therapy for non-small cell lung cancer 181
Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemtoherapy and surgery. A prospective evalation of a single institutional experience. 181
Oncological outcome of hypopharyngeal carcinoma treated with different modalities at two different university hospitals 181
Generator breast datamart—the novel breast cancer data discovery system for research and monitoring: Preliminary results and future perspectives 181
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 180
Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review 180
International consensus guidelines on Clinical Target Volume delineation in rectal cancer 179
Patients’ Satisfaction by SmileInTM Totems in Radiotherapy: A Two-Year Mono-Institutional Experience 178
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemoterapy and radioation therapy 177
Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy 177
The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy 177
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 176
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 176
Standardizing percutaneous Microwave Ablation in the treatment of Lung Tumors: a prospective multicenter trial (MALT study) 176
Evidence and research perspectives for surgeons in the European Rectal Cancer Consensus Conference (EURECA-CC2). 175
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 175
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 175
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 174
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 174
Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? 173
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 173
Minichromosome maintenance protein 7 and geminin expression: Prognostic value in laryngeal squamous cell carcinoma in patients treated with radiotherapy and cetuximab 173
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. 171
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 171
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 170
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 170
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 169
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 169
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 169
Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience 168
Reducing heart dose during left breast cancer radiotherapy: Comparison among 3 radiation techniques 167
Totale 22.496
Categoria #
all - tutte 333.035
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 333.035


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021111 0 0 0 0 0 0 0 0 0 0 0 111
2021/20225.268 516 307 103 411 252 171 80 723 232 348 1.135 990
2022/202311.225 1.570 1.538 869 1.747 675 1.314 566 874 1.249 240 412 171
2023/20245.589 231 1.532 225 369 241 860 325 299 80 195 581 651
2024/202511.732 313 362 890 433 1.125 419 416 538 1.695 1.282 2.297 1.962
2025/202630.338 4.464 806 1.542 3.207 5.145 2.578 5.070 1.497 1.988 2.187 1.017 837
Totale 80.126